原著論文

 

  1. Suzuki T, Funada M, Narita M, Misawa M and Nagase H: Pertussis toxin abolishes μ− and δ-agonist-induced place preference. Eur. J. Pharmacol., 205, 85-88 (1991) 査読有
  2. Suzuki T, Narita M, Misawa M and Nagase H: Pentazocine-induced biphasic analgesia in mice. Life Sci., 48, 1827-1835 (1991) 査読有
  3. Suzuki T, Narita M, Takahashi Y, Misawa M and Nagase H: Effect of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur. J. Pharmacol., 213, 91-97 (1992) 査読有
  4. Narita M, Suzuki T, Misawa M and Nagase H: Role of central ATP-sensitive potassium channels in the hyperthermic effect of morphine in mice. Psychopharmacol., 109, 239-240 (1992) 査読有
  5. Narita M, Suzuki T, Misawa M, Nagase H, Nabeshima A, Ashizawa T, Ozawa H, Saito T and Takahata N: Role of central ATP-sensitive potassium channels in the analgesic effect and spinal noradrenaline turnover enhancing effect of intracerebroventricularly injected morphine in mice. Brain Res., 596, 209-214 (1992) 査読有
  6. Narita M, Suzuki T, Funada M, Misawa M and Nagase H: Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by κ−opioid receptor activation in mice. Life Sci., 52, 397-404 (1993) 査読有
  7. Suzuki T, Takamori K, Takahashi Y, Narita M, Onodera K and Misawa M: Effects of histaminergic drugs on development of analgesic tolerance to morphine in mice. Res. Commun. Substance Abuse, 13, 323-339 (1992) 査読有
  8. Narita M, Suzuki T, Misawa M and Nagase H: Antagonism of the morphine-induced Straub tail reaction by κ−opioid receptor activation in mice. Psychopharmacology, 110, 254-256 (1993) 査読有
  9. Narita M, Takahashi Y, Suzuki T, Misawa M and Nagase H: An ATP-sensitive potassium channel blocker abolishes the potentiating effect of morphine on the bicuculline-induced convulsion in mice. Psychopharmacol., 110, 500-502 (1993) 査読有
  10. Suzuki T, Funada M, Narita M, Misawa M and Nagase H: Morphine-induced place preference in the CXBK mouse: Characteristics of μ opioid receptor subtypes. Brain Res., 602, 45-52 (1993) 査読有
  11. Narita M, Suzuki T, Funada M, Misawa M and Nagase H: Involvement of δ−opioid receptors of effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacol., 111, 423-426 (1993) 査読有
  12. Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M and Nagase H: Effects of κ-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Jpn. J. Pharmacol., 62, 15-24 (1993) 査読有
  13. Funada M, Suzuki T, Narita M, Misawa M and Nagase H: Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice. Brain Res., 619, 163-172 (1993) 査読有
  14. Funada M, Narita M, Suzuki T and Misawa M: Effect of pretreatment with pertussis toxin on the development of physical dependence on morphine. Naunyn-Schmiedeberg’s Arch. Pharmacol., 348, 88-95 (1993) 査読有
  15. Funada M, Suzuki T, Narita M, Misawa M and Nagase H: Blockade of morphine reward through the activation of κ−opioid receptors in mice. Neuropharmacol., 32, 1315-1323 (1993) 査読有
  16. Suzuki T, Takamori K, Takahashi Y, Narita M, Misawa M and Onodera K: The differential effects of histamine receptor antagonists on morphine- and U-50,488H-induced antinociception in the mouse. Life Sci., 54, 203-211 (1994) 査読有
  17. Narita M, Takamori K, Kawashima N, Funada M, Kamei J, Suzuki T, Misawa M and Nagase H: Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice. Psychopharmacol., 113,11-14 (1993) 査読有
  18. Kamei J, Kawashima N, Narita M, Suzuki T, Misawa M and Kasuya Y: Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice.  Psychopharmacol., 113, 318-321 (1994) 査読有
  19. Feng YZ, Narita M, Tseng YT, Hoskins B and Ho IK: Cross tolerance between butorphanol and morphine in rats. Pharmacol. Biochem. Behav., 49, 657-661 (1994) 査読有
  20. Narita M, Makimura M, Feng YZ, Hoskins B and Ho IK: Influence of chronic morphine treatment on protein kinase C activity: Comparison with butorphanol and implication for opioid tolerance. Brain Res., 650, 175-179 (1994) 査読有
  21. Feng YZ, Narita M, Makimura M, Hoskins B and Ho IK: Enhancement of the rate of GTP hydrolysis in rat brain by repeated κ−opioid treatment. Brain Res., 667,133-137 (1994) 査読有
  22. Narita M, Feng YZ, Makimura M, Hoskins B and Ho IK: A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception. Eur. J. Pharmacol., 271, 543-545 (1994) 査読有
  23. Narita M, Feng YZ, Makimura M, Hoskins B and Ho IK: Repeated administration of opioids alters characteristics of membrane-bound phorbol ester binding in rat brain. Eur. J. Pharmacol., 271, 547-550 (1994) 査読有
  24. Tseng LF, Collins KA, Narita M and Kampine JP: The use of antisense oligodeoxynucleotides to block the spinal effects of μ1 agonist-induced antinociception in the mouse. Analgesia, 1, 121-126 (1995) 査読有
  25. Narita M, Narita M, Mizoguchi H and Tseng LF: Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to intrathecally administered μopioid receptor agonist in the mouse. Eur. J. Pharmacol., 280, R1-R3 (1995) 査読有
  26. Mizoguchi H, Narita M and Tseng LF: Antisense oligodeoxynucleotide to a δ−opioid receptor blocks the antinociception induced by cold water swimming. Regul. Pept., 59, 255-259 (1995) 査読有
  27. Narita M and Tseng LF: Stimulation of spinal δ−opioid receptors in mice selectively enhances the attenuation of δ−opioid receptor mediated antinociception by antisense oligodeoxynucleotide. Eur. J. Pharmacol., 284, 185-189 (1995) 査読有
  28. Tseng LF, Narita M and Kampine JP: Pretreatment with β-endorphin facilitates the attenuation of δ−opioid receptor-mediated antinociception caused by δ−opioid receptor antisense oligodeoxynucleotide. Eur. J. Pharmacol., 287, 169-172 (1995) 査読有
  29. Makimura M, Narita M, Feng Y, Hoskins B and Ho IK: Influence of chronic treatment on low Km GTPase activity in rat brain: Evidence for the involvement of G-proteins in opioid tolerance. Brain Res. Bull., 38, 565-568 (1995) 査読有
  30. Feng YZ, Narita M, Makimura M, Hoskins B and Ho IK: Effects of repeated administration of κ−opioid agonist on phorbol ester binding to membrane-bound protein kinase C in rat brain. Biol. Pharm. Bull., 19, 303-304 (1996) 査読有
  31. Suzuki T, Tsuda M, Narita M, Funada M, Mizoguchi H and Misawa M: Diazepam pretreatment suppresses morphine withdrawal signs in the mouse. Life Sci., 58, 349-357 (1995) 査読有
  32. Mizoguchi H, Narita M, Nagase H, Suzuki T, Quock RM and Tseng LF: Use of antisense oligodeoxynucleotide to determine δ−opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity. Life Sci., 59, PL69-73 (1996) 査読有
  33. Narita M, Mizoguchi H, Kampine JP and Tseng LF: Role of protein kinase C in desensitization of spinal δ−opioid-mediated antinociception in the mouse. Br. J. Pharmacol., 118, 1829-1835 (1996) 査読有
  34. Mizoguchi H, Narita M, Kampine JP and Tseng LF: Pretreatment with pertussis toxin spinally, but not supraspinally, blocks cold water swimming-induced antinociception in the mouse. Eur. J. Pharmacol., 309, 37-40 (1996) 査読有
  35. Narita M, Mizoguchi H and Tseng LF: Phorbol ester blocks the increase of a high affinity GTPase activity induced by δ−2-opioid receptor agonist in the mouse spinal cord. Eur. J. Pharmacol., 310, R1-3 (1996) 査読有
  36. Narita M, Dun SL, Dun NJ and Tseng LF: Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord. Eur. J. Pharmacol., 311, 121-126 (1996) 査読有
  37. Narita M, Ohsawa M, Mizoguchi H, Kamei J and Tseng LF: Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by μ but not ε−opioid receptor agonist in the mouse. Neuroscience, 76, 291-298 (1997) 査読有
  38. Narita M, Mizoguchi H, Kampine JP and Tseng LF: The effect of pretreatment with a δ2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to δ−2-opioid receptor agonist in the mouse spinal cord. Br. J. Pharmacol., 120, 587-592 (1997) 査読有
  39. Tseng LF, Narita M, Mizoguchi H, Kawai K, Mizusuna A, Kamei J, Suzuki T and Nagase H: Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67 in the mouse spinal cord. J. Pharmacol. Exp. Ther., 280, 600-605 (1997) 査読有
  40. Suzuki T, Tsuji M, Ikeda H, Misawa M, Narita M and Tseng LF: Antisense oligodeoxynucleotide to δ− opioid receptors blocks cocaine-induced place preference in mice. Life Sci., 60, PL283-288 (1997) 査読有
  41. Mizoguchi H, Narita M, Kampine JP and Tseng LF: [Met5]enkephalin and δ−2-opioid receptors in the spinal cord are involved in the cold water swimming-induced antinociception in the mouse. Life Sci., 61, PL81-86 (1997) 査読有
  42. Kamei J, Kawai K, Mizusuna A, Saitoh A, Morita K, Narita M, Tseng LF and Nagase H: Supraspinal δ−1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice. Eur. J. Pharmacol., 322, 27-30 (1997) 査読有
  43. Narita M, Mizoguchi H, Nagase H and Tseng LF: Use of antisense oligodeoxynucleotide to δ−opioid receptor mRNA in the study of the turnover of δ−opioid receptors in the spinal cord of the mouse. Psychopharmacol., 133, 347-350 (1997) 査読有
  44. Narita M, Mizoguchi H, Oji GS, Tseng EL, Suganuma C, Nagase H and Tseng LF: Characterization of endomorphin-1 and -2 on [35S]GTPγS binding in the mouse spinal cord.  Eur. J. Pharmacol., 351, 383-387 (1998) 査読有
  45. Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR and Tseng LF: Absence of G-protein activation by μopioid receptor agonists in the spinal cord of μopioid receptor knockout mice. Br. J. Pharmacol., 126, 451-456 (1999) 査読有
  46. Tsuji M, Narita M, Mizoguchi H, Narita M, Ohsawa M, Kamei J, Nagase H, Takeda H, Matsumiya T and Tseng LF: Region-dependent G-protein activation by μ−, δ1- and δ−2-opioid receptor agonists in the brain: Comparison between the midbrain and forebrain. Life Sci., 65, 233-239 (1999) 査読有
  47. Endoh T, Matsuura H, Tajima A, Izumimoto N, Tajima C, Suzuki T, Saitoh A, Suzuki T, Narita M, Tseng LF and Nagase H: Potent antinociceptive effects of TRK-820, a novel κ−opioid receptor agonist. Life Sci., 65, 1685-1694 (1999) 査読有
  48. Narita M, Mizoguchi H, Oji DE, Narita M, Dun NJ, Hwang BH, Nagase H and Tseng LF: Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]GTPγ−S binding and immunohistochemistry. Br. J. Pharmacol., 128, 1300-1306 (1999) 査読有
  49. Mizoguchi H, Narita M, Oji DE, Suganuma C, Nagase H, Sora I, Uhl GR, Cheng EY and Tseng LF: The μ−opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ−opioid receptor knockout mice. Neuroscience, 94, 203-207 (1999) 査読有
  50. Narita M, Aoki T and Suzuki T: Molecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference. Neuroscience, 101, 601-606 (2000) 査読有
  51. Mizoguchi H, Narita M, Nagase H and Tseng LF: Activation of G-proteins in the mouse pons/medulla by β−endorphin is mediated by the stimulation of μ− and putative ε−receptors. Life Sci., 67, 2733-2743 (2000) 査読有
  52. Yamazaki M, Mizoguchi H, Ohsawa M, Tseng LF, Suzuki T and Narita M: Implication of Ca2+-activated Cl- channels in the δ−opioid receptor mediated antinociception in the mouse spinal cord. Neurosci. Lett., 295, 113-115 (2000) 査読有
  53. Mizoguchi H, Narita M, Wu H, Narita M, Suzuki T, Nagase H and Tseng LF: Differential involvement of μ−1-opioid receptors in endomorphin- and β−endorphin-induced G-protein activation in the mouse pons/medulla. Neuroscience., 100, 835-839 (2000) 査読有
  54. Suzuki T, Kato H, Aoki T, Tsuda M, Narita M and Misawa M: Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. Life Sci., 67, 383-389 (2000) 査読有
  55. Ohsawa M, Narita M, Mizoguchi H, Suzuki T and Tseng LF: Involvement of spinal protein kinase C in thermal hyperalgesia evoked by partial sciatic nerve ligation, but not by inflammation in the mouse. Eur. J. Pharmacol., 403, 81-85 (2000) 査読有
  56. Ise Y, Narita M, Nagase H and Suzuki T: Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacol., 151, 49-54 (2000) 査読有
  57. Ohsawa M, Mizoguchi H, Narita M, Chu M, Nagase H and Tseng LF: Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther., 294, 1106-1111 (2000) 査読有
  58. Narita M, Ohsawa M, Mizoguchi H, Aoki T, Suzuki T and Tseng LF: Role of the phosphatidylinositol-specific phospholipase C pathway in μ−opioid receptor-mediated antinociception in the mouse spinal cord. Neuroscience, 99, 327-331 (2000) 査読有
  59. Narita M, Soma M, Mizoguchi H, Tseng LF and Suzuki T: Implication of the NR2B subunit-containing NMDA receptor localized in mouse limbic forebrain in ethanol dependence. Eur. J. Pharmacol., 401, 191-195 (2000) 査読有
  60. Narita M, Yajima Y, Aoki T, Ozaki S, Mizoguchi H, Tseng LF and Suzuki T: Up-regulation of the TrkB receptor in mice injured by the partial ligation of the sciatic nerve. Eur. J.  Pharmacol., 401, 187-190 (2000) 査読有
  61. Ohsawa M, Mizoguchi H, Narita M, Kamei J, Nagase H and Tseng LF: Effects of a μ−opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice. Eur. J. Pharmacol., 401, 55-58 (2000) 査読有
  62. Tsuji M, Takeda H, Matsumiya T, Nagase H, Yamazaki M, Narita M and Suzuki T: A novel κ−opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice. Life Sci., 66, PL353-358 (2000) 査読有
  63. Suzuki T, Aoki T, Ohnishi O, Nagase H and Narita M: Different effects of NMDA/group I metabotropic glutamate receptor agents in μ− and δ−opioid receptor agonist-induced supraspinal antinociception. Eur. J. Pharmacol., 396, 23-28 (2000) 査読有
  64. Narita M, Mizoguchi H, Narita M, Dun NJ, Hwang BH, Endoh T, Suzuki T, Nagase H, Suzuki T and Tseng LF: G protein activation by endomorphins in the mouse periaqueductal gray matter. J. Biomed. Sci., 7, 221-225 (2000) 査読有
  65. Yajima Y, Narita M, Takahashi-Nakano Y, Misawa M, Nagase H, Mizoguchi H, Tseng LF and Suzuki T: Effects of differential modulation of μ−, δ− and κ−opioid systems on bicuculline-induced convulsions in the mouse. Brain Res., 862, 120-126 (2000) 査読有
  66. Tsuji M, Yamazaki M, Takeda H, Mastumiya T, Nagase H, Tseng LF, Narita M and Suzuki T: The novel κ−opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice. Eur. J. Pharmacol., 394, 91-95 (2000) 査読有
  67. Endoh T, Tajima A, Suzuki T, Kamei J, Narita M, Tseng LF and Nagase H: Characterization of the antinociceptive effects of TRK-820 in the rat. Eur. J. Pharmacol., 387, 133-140 (2000) 査読有
  68. Tseng LF, Narita M, Suganuma C, Mizoguchi H, Ohsawa M, Nagase H and Kampine JP: Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther., 292, 576-583 (2000) 査読有
  69. Yajima Y, Narita M, Tsuda M, Imai S, Kamei J, Nagase H and Suzuki T: Modulation of NMDA- and (+)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord. Life Sci., 68, 719-725 (2000) 査読有
  70. Hamura H, Yoshida M, Shimizu K, Matsukura T, Suzuki H, Narita M and Suzuki T: Antinociceptive effect of the combination of pentazocine with morphine in the tail-immesion and scald-pain tests in rats. Jpn. J. Pharmacol., 83, 286-292 (2000) 査読有
  71. Endoh T, Tajima A, Izumimoto N, Suzuki T, Saitoh A, Suzuki T, Narita M, Kamei J, Tseng LF, Mizoguchi H, and Nagase H: TRK-820, a selective κ−opioid agonist, produces potent antinociception in cynomolgus monkeys. Jpn. J. Pharmacol., 85, 282-290 (2001) 査読有
  72. Tsuji M, Takeda H, Mastumiya T, Nagase H, Narita M and Suzuki T: The novel κ−opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice. Life Sci., 68, 1717-1725 (2001) 査読有
  73. Ise Y, Katayama S, Hirano M, Aoki T, Narita M and Suzuki T: Effects of fluvoxamine in morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice. Neurosci Lett., 299, 29-32 (2001) 査読有
  74. 成田 年, 大西織江, 根本真記, 青木 健, 鈴木 勉: Morphine 誘発抗侵害効果の発現に対する phosphoinositide3-kinase および phospholipase Cγ の関与. 日本神経精神薬理学雑誌 21, 7-14 (2001) 査読有
  75. Yamazaki M, Suzuki T, Narita M and Lipkowski AW: The opioid peptide analogue biphalin induces less physical dependence than morphine. Life Sci., 69, 1023-1028 (2001) 査読有
  76. Narita M, Yoshizawa K, Aoki K, Takagi M, Miyatake M and Suzuki T: A putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in rats. Addiction Biol., 6, 373-376 (2001) 査読有
  77. Nagase H, Yajima Y, Fujii H, Kawamura K, Narita M, Kamei J and Suzuki T: The pharmacological profile of δ− opioid receptor ligands, (+) and (-) TAN-67 on pain modulation. Life Sci., 68, 2227-31 (2001) 査読有
  78. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Kampine JP and Tseng LF: Differential antinociception induced by spinally administerd endmorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther., 298, 592-597 (2001) 査読有
  79. Narita M, Yoshizawa K, Nomura M, Aoki K and Suzuki T: Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine. Eur. J. Pharmacol., 423, 41-46 (2001) 査読有
  80. 成田 年, 瀧本 淳, 相馬 仁, 矢島義識, 水尾圭祐, 黒木由夫, 鈴木 勉: Morphine 誘発自発運動促進作用に対する逆耐性形成時の μ−opioid 受容体機能変化.日本神経精神薬理学会雑誌 21, 55-61 (2001) 査読有
  81. Narita M, Tamaki H, Kobayash M, Sohma M, Narita M and Suzuki T: Changes in Ca2+-dependent protein kinase C isoforms induced by chronic ethanol treatment in mice. Neurosci. Lett., 307, 85-88 (2001) 査読有
  82. Narita M, Ozaki S, Ioka M, Mizoguchi H, Nagase H, Tseng LF and Suzuki T: Lack of the involvement of μ1-opioid receptor subtype on motivational effects induced by the endogenous μ−opioid receptor ligands endomorphin-1 and -2 in the mouse. Neurosci. Lett., 308, 17-20 (2001) 査読有
  83. Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, Fujimura T, Murayama K, Sakurada C, Sakurada T, Narita M, Suzuki T, Tan-no K and Tseng LF: Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur. J. Pharmacol., 427, 203-10 (2001) 査読有
  84. Mizoguchi H, Wu HE and Narita M: Partial agonistic action of endomorphins in the mouse spinal cord. Neurosci. Lett., 310, 66-68 (2001) 査読有
  85. Ohsawa M, Shirakim M, Mizoguchi H, Narita M, Kawai K, Nagase H, Cheng EY, Narita M and Tseng LF: Release of [Met5]enkephalin from the spinal cord by intraventricularly administered endomorphin-2, but not endomorphin-1 in the anesthetized rat. Neurosci. Lett., 316, 1-4 (2001) 査読有
  86. Narita M, Aoki T, Ozaki S, Yajima Y and Suzuki T: Involvement of protein kinase Cγ isoform in morphine-induced reinforcing effects. Neuroscience, 103, 309-314 (2001) 査読有
  87. Narita M, Ozaki S, Ioka M, Mizoguchi H, Nagase H, Tseng LF and Suzuki T: Different motivational effects induced by the endogenous μ−opioid receptor ligands endomorphin-1 and -2 in the mouse. Neuroscience, 105, 213-218 (2001) 査読有
  88. Narita M, Mizoguchi H, Suzuki T, Narita M, Dun NJ, Imai S, Yajima Y, Nagase H, Suzuki T and Tseng LF: Enhanced μ−opioid responses in the spinal cord of mice lacking protein kinase Cγ J. Biol. Chem., 276, 15409-15414 (2001) 査読有
  89. Narita M, Mizoguchi H, Narita M, Nagase H, Suzuki T and Tseng LF: Involvement of spinal protein kinase Cγ in the attenuation of opioid μ−receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2, N-MePhe4,Gly-Ol5] enkephalin. J. Neurosci., 21, 3715-3720 (2001) 査読有
  90. Narita M, Mizoguchi H, Nagase H, Suzuki T and Tseng LF: Up-regulation of spinal μ−opioid receptor function to activate G-protein by chronic naloxone treatment. Brain Res., 913, 170-173 (2001) 査読有
  91. Ohsawa M, Narita M, Mizoguchi H, Cheng EY and Tseng LF: Reduced hyperanalgesia induced by nerve injury, but not by inflammation in mice lacking protein kinase Cγ isoform. Eur. J. Pharmacol., 429, 157-160 (2001) 査読有
  92. Yamazaki M, Suzuki T, Narita M and Lipkowski AW: The opioid peptide analogue biphalin induces less physical dependence than morphine. Life Sci., 69, 1023-1028 (2001) 査読有
  93. Suzuki T, Kishimoto Y, Ozaki S and Narita M: Mechanism of opioid dependence and interaction between opioid receptors. Eur. J. Pain, 5, 63-65 (2001) 査読有
  94. Narita M, Mizuo K, Shibasaki M, Narita M and Suzuki T: Up-regulation of the Gq/11a protein and protein kinase C during the development of sensitization to morphine-induced hyperlocomotion. Neuroscience , 111, 127-132 (2002) 査読有
  95. Narita M, Imai S, Itou Y, Yajima Y and Suzuki T: Possible involvement of μ−1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites. Life Sci., 70, 2341-2354 (2002) 査読有
  96. Ise Y, Narita M, Nagase H and Suzuki T: Modulation of κ−opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Neurosci. Lett., 323, 164-166 (2002) 査読有
  97. Narita M, Ioka M, Suzuki M, Narita M and Suzuki T: Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain. Neurosci. Lett., 324, 97-100 (2002) 査読有
  98. Narita M, Ohnishi O, Nemoto M, Yajima Y and Suzuki T: Implication of phosphoinositide 3-kinase in the μ− and δ−opioid receptor-mediated supraspinal antinociception in the mouse. Neuroscience, 113, 647-652 (2002) 査読有
  99. Mori T, Nomura M, Nagase H, Narita M and Suzuki T: Effects of a newly synthesized κ−opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Psychopharmacol., 161, 17-22 (2002) 査読有
  100. Mori T, Narita M, Onodera K and Suzuki T: Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system. Jpn. J. Neuropsychopharmacol., 22, 73-78 (2002) 査読有
  101. Narita M, Soma M, Tamaki H, Narita M and Suzuki T: Intensification of the development of ethanol dependence in mice lacking dopamine D3 receptor. Neurosci. Lett., 324, 129-132 (2002) 査読有
  102. Mizoguchi H, Wu HE, Narita M, Hall FS, Sora I, Uhl GR, Nagase H and Tseng LF: Antagonistic property of buprenorphine for putative ε−opioid receptor-mediated G-protein activation by β−endorphine in pons/medulla of the μ−opioid receptor knockout mouse. Neuroscience, 115, 715-721 (2002) 査読有
  103. Ozaki S, Narita M, Narita M, Iino M, Sugita J, Matsumura Y and Suzuki T: Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: Implication of the reduction of in μ−opioid receptor function in the ventral tegmental area. J. Neurochem., 82, 1192-8 (2002) 査読有
  104. Yajima Y, Narita M, Narita M, Matsumoto N and Suzuki T: Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice. Brain Res., 958, 338-346 (2002) 査読有
  105. Narita M, Mizoguchi H, Khotib J, Suzuki M, Ozaki S, Yajima Y, Narita M, Tseng LF and Suzuki T: Influence of a deletion of protein kinase Cγ soform in the G-protein activation mediated through opioid receptor-like-1 and μ−opioid receptors in the mouse pons/medulla. Neurosci. Lett., 331, 5-8 (2002) 査読有
  106. Mizoguchi H, Hung KC, Leitermann R, Narita M, Nagase H, Suzuki T and Tsegn LF: Blockade of μ−opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice. Eur. J. Pharmacol., 461, 35-39 (2003) 査読有
  107. Mizoguchi H, Wu HE, Narita M, Loh HH, Nagase H and Tseng LF: Loss of μ−opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exon 2 & 3 of μ−opioid receptor gene. Neurosci. Lett., 335, 91-94 (2002) 査読有
  108. Ozaki S, Narita M, Narita M, Iino M, Miyoshi K and Suzuki T: Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: Involvement of G-protein-coupled receptor kinase 2. Neuroscience, 116, 89-97 (2003) 査読有
  109. Narita M, Suzuki M, Mizoguchi H, Narita M, Yajima Y, Sakurada S, Tseng LF and Suzuki T: Up-regulation of μ−opioid receptor-mediated G-protein activation in protein kinase Cγ knockout mice following repeated naloxone treatment. Neurosci. Lett., 338, 103-106 (2003) 査読有
  110. Narita M, Mizuo K, Mizoguchi H, Sakata M, Narita M, Tseng LF and Suzuki T: Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J. Neurosci., 23, 1006-1012 (2003) 査読有
  111. Narita M, Ohnishi O, Narita M, Aoki T, Suzuki M, Yajima Y, Funahashi H, Shioda S and Suzuki T: Direct evidence for the activation of phosphlipase Cγ1 by in vivo treatment with morphine in the mouse periaqueductal gray matter. Brain Res., 970, 140-148 (2003) 査読有
  112. Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S, Shirai T and Narita M: Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience, 117, 639-644 (2003) 査読有
  113. Narita M, Aoki K, Takagi M, Yajima Y and Suzuki T: Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience, 119, 767-775 (2003) 査読有
  114. Narita M, Khotib J, Suzuki M, Ozaki S, Yajima Y and Suzuki T: Heterologous μ−opioid receptor adaptation by repeated stimulation of κ−opioid receptor: Up-regulation of G-protein activation and antinociception. J. Neurochem., 85, 1171-1179 (2003) 査読有
  115. Narita M, Shibasaki M, Mizuo K and Suzuki T: Change in G-protein activity mediated through the stimulation of dopamine and GABAB receptors in the mesolimbic dopaminergic system of morphine-sensitized mice: Change in G-protein activity in morphine-sensitized mice. Addict. Biol., 8,319-325 (2003) 査読有
  116. Narita M, Takagi M, Aoki K, Kuzumaki N and Suzuki T: Implication of Rho-associated kinase in the elevation extracellular dopamine levels and its related behaviors induced by methamphetamine in rat: Rho/ROCK pathway controls the methamphetamine-induced actions. J. Neurochem., 86, 273-282 (2003) 査読有
  117. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Dun NJ and Tseng LF: Involvement of β−arrestin-2 modulation of the spinal antinociception induced by μ−opioid receptor agonists in the mouse. Neurosci. Lett., 346, 13-16 (2003) 査読有
  118. Aoki T, Narita M, Ohnishi O, Mizuo K, Narita M, Yajima Y and Suzuki T: Disruption of type 1 inositol 1,4,5-triphosphate receptor gene suppresses the morphine-induced antinociception in the mouse. Neurosci. Lett., 350, 69-72 (2003) 査読有
  119. Narita M, Khotib J, Mizoguchi H, Suzuki M, Ozaki S, Yajima Y, Tseng LF and Suzuki T: Direct evidence for the up-regulation of spinal μ−opioid receptor function after repeated stimulation of κ−opioid receptors in the mouse. Eur. J. Neurosci., 18, 2498-2504 (2003) 査読有
  120. Narita M, Ozaki S, Narita M, Ise Y, Yajima Y and Suzuki T: Change in the expression of c-fos in the rat brain following sciatic nerve ligation. Neurosci. Lett., 352, 231-233 (2003) 査読有
  121. Yajima Y, Narita M, Shimamura M, Narita M, Kubota T and Suzuki T: Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice. Brain Res., 992, 288-293 (2003) 査読有
  122. Narita M, Imai S, Ozaki S, Suzuki M, Narita M and Suzuki T: Reduced expression of a novel μ−opioid receptor (MOR) subtype MOR-1B in CXBK mice: Implications of MOR-1B in the expression of MOR-mediated responses. Eur. J. Neurosci., 18, 3193-3198 (2003) 査読有
  123. Narita M, Kuzumaki N, Suzuki M, Narita M, Oe K, Yamazaki M, Yajima Y and Suzuki T: Increased phosphorylated-μ−opioid receptor immunoreactivity in the mouse spinal cord following sciatic nerve ligation. Neurosci. Lett., 354, 148-152 (2004) 査読有
  124. Narita M, Imai S, Narita M., Kasukawa A, Yajima Y and Suzuki T: Increased level of neuronal phosphoinositide 3-kinase γ by the activation of μ−opioid receptor in the mouse periaqueductal gray matter: Further evidence for the implication in morphine-induced antinociception. Neuroscience, 124, 515-521 (2004) 査読有
  125. Mizoguchi H, Leitermann, R. J. Narita M, Nagase H, Suzuki T and Tseng LF: Region-dependent G-protein activation by κ−opioid receptor agonists in the mouse brain. Neurosci. Lett., 356, 145-147 (2004) 査読有
  126. Mizuo K, Narita M, Miyatake M and Suzuki T: Enhancement of dopamine-induced signaling responses in the forebrain of mice lacking dopamine D3 receptor. Neurosci. Lett., 358, 13-16 (2004) 査読有
  127. Narita M, Oe K, Kato H, Shibasaki M, Narita M, Yajima Y, Yamazaki M and Suzuki T: Implication of spinal protein kinase C in the suppression of morphine-induced rewarding effect under a neruopathic pain-like state in mice. Neuroscience, 125, 545-551 (2004) 査読有
  128. Narita M, Matsumura Y, Ozaki S, Ise Y, Yajima Y and Suzuki T: Role of the calcium/calmodulin-dependent protein kinese II (CaMKII) in the morphine-induced pharmacological effects in the mouse. Neuroscience, 126, 415-421(2004) 査読有
  129. Mori T, Narita M, Onodera K and Suzuki T: Involvement of histaminergic system in the discriminative stimulus effects of morphine. Eur. J. Pharmacol., 491, 169-172 (2004) 査読有
  130. Narita M, Imai S, Oe K, Narita M, Kubota C, Yajima Y, Yamazaki M and Suzuki T: Induction of c-fos expression in the mouse brain associated with hyperalgesia induced by intrathecal injection of protein kinase C activator. Brain Res., 1015, 189-193 (2004) 査読有
  131. Oe K, Narita M, Imai S, Shibasaki M, Kubota C, Kasukawa A, Hamaguchi M, Yajima Y, Yamazaki M and Suzuki T: Inhibition of the morphine-induced rewarding effect by direct activation of spinal protein kinase C in mice. Psychopharmacol., 177, 55-60 (2004) 査読有
  132. Mizuo K, Narita M, Yoshida T, Narita M and Suzuki T: Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol-A in mice. Addict. Biol., 9, 19-25 (2004) 査読有
  133. Narita M, Akai H, Nagumo Y, Sunagawa N, Hasebe K, Nagase H,Kita T, Hara C and  Suzuki T: Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in the rats. Neuroscience, 127, 941-948 (2004) 査読有
  134. Suzuki T, Fukuoka Y, Mori T, Miyatake M and Narita M: Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats. Eur. J. Pharmacol., 498, 157-161 (2004) 査読有
  135. Mori T, Nomura M, Yoshizawa K, Nagase H, Narita M and Suzuki T: Differential propeties between TRK-820 and U-50, 488H on the discriminative stimulus effects in rats. Life Sci., 75, 2473-2482 (2004) 査読有
  136. Fujii H, Narita M, Mizoguchi H, Hirokawa J, Kawai K, Tanaka T, Tseng LF and Nagase H: Rational drug design and synthesis of a selective ε− opioid receptor antagonist on the basis of the accessory site concept. Bioorg. Med. Chem., 14, 4241-4243 (2004) 査読有
  137. Aoki T, Narita M, Shibasaki M and Suzuki T: Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice. Eur. J. Neurosci., 20, 1633-1638 (2004) 査読有
  138. Narita M, Suzuki M, Yajima Y, Suzuki R, Shioda S and Suzuki T: Neuronal protein kinase C γdependent proliferation and hypertrophy of spinal cord astrocytes following repeated in vivo administration of morphine. Eur. J. Neurosci., 19, 479-484 (2004) 査読有
  139. Mizuo K, Narita M, Miyagawa K, Narita M, Okuno E and Suzuki T: Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice. Neurosci. Lett., 356, 95-98. (2004) 査読有
  140. Khotib J, Narita M, Narita M, Suzuki M, Yajima Y and Suzuki T: Functional interaction among opioid receptor types: up-regulation of μ− and δ−opioid receptor functions after repeated stimulation of κ−opioid receptors. Neuropharmacol., 46, 531-540. (2004) 査読有
  141. Ozaki S, Narita M, Ozaki M, Khotib J and Suzuki T: Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation. J. Neurochem., 88, 1389-1397. (2004) 査読有
  142. Fujii H, Narita M, Mizoguchi H, Murachi M, Tanaka T, Kawai K, Tseng LF and Nagase H: Drug design and synthesis of ε− opioid receptor agonist: 17-(cyclopropylmethyl)-4,5a-epoxy-3,6β−dihydroxy-6,14-endoethenomorphinan-7a-(N-methyl-N-phenethyl) carboxamide (TAN-821) inducing antinociception mediated by putative ε− opioid receptor. Bioorg. Med. Chem., 12, 4133-4145. (2004) 査読有
  143. Mori T, Ito S, Narita M, Suzuki T and Sawaguchi T: Combined effects of psychostimulants and morphine on locomotor activity in mice. J. Pharmacol. Sci., 96, 450-458. (2004) 査読有
  144. Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K and Suzuki T: Direct evidence for the involvement of the mesolimbic κ−opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology, 30, 111-118, (2005) 査読有
  145. Yajima Y, Narita M, Usui A, Kaneko C, Miyatake M, Narita M, Yamaguchi T, Tamaki H, Wachi H, Seyama Y and Suzuki T: Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice. J. Neurochem., 93, 584-594, (2005) 査読有
  146. Narita M, Akai H, Kita T, Nagumo Y, Narita M, Sunagawa N, Hara C, Hasebe K, Nagase H and Suzuki T: Involvement of mitogen-stimulated p70-S6 kinase in the development of sensitization to the methamphetamine-induced rewarding effect in rats. Neuroscience, 132, 553-560, (2005) 査読有
  147. Higashiyama K, Takeuchi Y, Yamauchi T, Imai S, Kamei J, Yajima Y, Narita M and Suzuki T: Implication of the descending dynorphinergic neuron projecting to the spinal cord in the (+)-matrine- and (+)-allomatrine-induced antinociceptive effects. Biol. Pharm. Bull., 28, 845-848, (2005) 査読有
  148. Narita M, Miyatake M, Shibasaki M, Tsuda M, Koizumi S, Narita M, Yajima Y, Inoue K and Suzuki T: Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization. J. Neurochem., 93, 1383-1392 (2005) 査読有
  149. Narita M, Shibasaki M, Nagumo Y, Narita M, Yajima Y and Suzuki T: Implication of cyclin-dependent kinase 5 in the development of psychological dependence on and behavioral sensitization to morphine. J. Neurochem., 93, 1463-1468, (2005) 査読有
  150. Narita M, Kato H, Miyoshi K, Aoki T, Yajima Y and Suzuki T: Treatment for psychological dependence on morphine: Usefulness of inhibiting NMDA receptor and its associated protein kinase in the nucleus accumbens. Life Sci., 77, 2207-2220, (2005) 査読有
  151. Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Aoki T, Yajima Y and Suzuki T: Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine-induced antinociception. J. Neurochem., 94, 1297-1305, (2005) 査読有
  152. Miyatake M, Narita M, Sibasaki M, Nakamura A and Suzuki T: Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence. Eur. J. Neurosci., 22, 1476-1488, (2005) 査読有
  153. Suzuki T, Nurrochmad A, Ozaki M, Khotib J, Nakamura A, Imai S, Shibasaki M, Yajima Y and Narita M: Effect of a selective GABAB receptor agonist baclofen on the μ−opioid receptor agonist-induced antinociceptive, emetic and rewarding effects. Neuropharmacol., 49, 1121-1131, (2005) 査読有
  154. Narita M, Usui A, Narita M, Niikura K, Nozaki H, Khotib J, Nagumo Y, Yajima Y and Suzuki T: Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons is implicated in neuropathic pain after nerve injury. J. Neurosci., 25, 10000-10009, (2005) 査読有
  155. 成田 年、宮川和也、成田道子、水尾圭祐、宮竹真由美、鈴木勉: ストレス曝露による 5-HT1A 受容体の機能変化と 5-HT1A 受容体を介した神経保護作用. 日本神経精神薬理学雑誌 25, 91-104, (2005) 査読有
  156. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M and Suzuki T: Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacol., 31, 739-750 (2006) 査読有
  157. Kato H, Narita M, Miyatake M, Yajima Y and Suzuki T: Role of neuronal NR2B subunit-containing NMDA receptor-mediated Ca2+ influx and astrocytic activation in cultured mouse cortical neurons and astrocytes. Synapse, 59, 10-17 (2006) 査読有
  158. Narita M, Kuzumaki N, Narita M, Kaneko C, Tamaki E, Khotib J, Miyatake M, Shindo K, Tanaka S and Suzuki T: Age-related emotionality is associated with cortical δ−opioid receptor dysfunction-dependent astrogliosis. Neuroscience, 137, 1359-1367 (2006) 査読有
  159. Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S and Suzuki T: Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci., 26, 398-405 (2006) 査読有
  160. Narita M, Kato H, Kasukawa A, Narita M, Suzuki M, Takeuchi T and Suzuki T: Role of Src family kinase in the reward and hyperlocomotion induced by morphine. Neuroreport, 17, 115-119 (2006) 査読有
  161. Narita M, Miyatake M, Narita M, Shibasaki M, Shindo K, Nakamura A, Kuzumaki N, Nagumo Y and Suzuki T: Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacol., 31, 2476-2488 (2006) 査読有
  162. Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Yajima Y, Suzuki T: μ−Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to μ−opioid receptor agonists: Comparison between etorphine and morphine. Neuroscience, 138, 609-619 (2006) 査読有
  163. Mori T, Ito S, Kita T, Narita M, Suzuki T and Sawaguchi T: Effects of μ−, δ− and κ−opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice. Eur. J. Pharmacol., 532, 81-87 (2006) 査読有
  164. Mori T, Nomura M, Yoshizawa, K, Nagase H, Sawaguchi T, Narita M and Suzuki T: NMDA-receptor antagonists to the discriminative stimulus effects of κ−opioid receptor agonists U-50, 488H, but not TRK-820 in rats. J. Pharmacol. Sci., 100, 157-161 (2006) 査読有
  165. Suzuki M, Narita M, Narita M, Niikura K and Suzuki T: Chronic morphine treatment increases the expression of the neural cell adhesion molecule in the dorsal horn of the mouse spinal cord. Neurosci. Lett., 399, 202-205 (2006) 査読有
  166. Suzuki M, Narita M, Nakamura A and Suzuki T: Role of gap junction in the expression of morphine-induced antinociception. Eur. J. Pharmacol., 535, 169-171 (2006) 査読有
  167. Suzuki M, Narita M, Narita M and Suzuki T: Chronic morphine treatment increases the expression of vesicular glutamate transporter 1 in the mouse spinal cord. Eur. J. Pharmacol., 535, 166-168 (2006) 査読有
  168. Narita M, Yoshida T, Nakajima M, Narita M, Miyatake M, Takagi T, Yajima Y and Suzuki T: Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J. Neurochem., 97, 1337-1348 (2006) 査読有
  169. Narita M, Miyagawa K, Mizuo K, Yoshida T and Suzuki T: Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect. Neurosci. Lett., 402, 249-252 (2006) 査読有
  170. Miyatake M, Miyagawa K, Mizuo K, Narita M and Suzuki T: Dynamic changes in dopaminergic neurotransmission induced by a low concentration of bisphenol-A in neurones and astrocytes. J. Neuroendocrinol., 18, 434-444 (2006) 査読有
  171. Narita M, Kuzumaki N, Narita M, Kaneko C, Hareyama N, Miyatake M, Shindo K, Miyoshi K, Nakajima M, Nagumo Y, Sato F, Wachi H, Seyama Y and Suzuki T: Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical δ−opioid receptor dysfunction. J. Neurochem., 97, 1369-1378 (2006) 査読有
  172. Narita M, Kuzumaki N, Miyatake M, Sato F, Wachi H, Seyama Y and Suzuki T: Role of delta-opioid receptor function in neurogenesis and neuroprotection. J. Neurochem., 97, 1494-1505 (2006) 査読有
  173. Kato H, Narita M, Miyoshi K, Narita M, Asato M, Hareyama N, Nozaki H, Takagi T, Suzuki M and Suzuki T: Implication of Src family kinase-dependent phosphorylation of NR2B subunit-containing NMDA receptor in the rewarding effect of morphine. Jpn. J. Neuropsychopharmacol., 26, 119-124 (2006) 査読有
  174. Miyoshi K, Narita M, Narita M and Suzuki T: Involvment of mGluR5 in the ethanol-induced neuropathic pain-like state in the rat. Neurosci. Lett. 410, 105-109 (2006) 査読有
  175. Imai S, Narita M, Hashimoto S, Nakamura A, Miyoshi K, Nozaki H, Hareyama N, Takagi T, Suzuki M, Narita M and Suzuki T: Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under the pain-like state. Jpn. J. Neuropsychopharmacol., 26, 183-192 (2006) 査読有
  176. Narita M, Miyoshi K, Narita M, Suzuki T: Functional reduction in μ−opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat. Neuroscience, 144, 777-782 (2007) 査読有
  177. Narita M, Miyoshi K, Narita M, Suzuki T: Changes in function of NMDA receptor NR2B subunit in spinal cord of rats with neuropathy following chronic ethanol consumption. Life Sci. 80, 852-859 (2007) 査読有
  178. Kuzumaki N, Narita M, Narita M, Hareyama N, Niikura K, Nagumo Y, Nozaki H, Amano T and Suzuki T: Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice. Neurosci. Lett., 415, 22-27 (2007) 査読有
  179. Narita M, Nagumo Y, Miyatake M, Ikegami D, Kurahashi K and Suzuki T: Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Eur. J. Neurosci. 25, 1537-1545 (2007) 査読有
  180. Miyagawa K, Narita M, Narita M, Niikura K, Akama H, Tsurukawa Y and Suzuki T: Changes in central dopaminergic systems with the expression of Shh and GDNF in mice perinatally exposed to bisphenol-A. Jpn. J. Neuropsychopharmacol., 27, 69-75 (2007) 査読有
  181. Miyagawa K, Narita M, Narita M, Akama H and Suzuki T: Memory impairment associated with a dysfunction of the hippocampal cholinergic system induced by prenatal and neonatal exposures to bisphenol-A. Neurosci. Lett. 418, 236-241 (2007) 査読有
  182. Narita M, Miyoshi K, Narita M and Suzuki T: Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat. Neurosci. Lett., 414, 21-25 (2007) 査読有
  183. Narita M, Miyagawa K, Mizuo K, Yoshida T, Suzuki T: Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol-A in mice: Evidence for the importance of exposure period. Addict. Biol., 12, 167-172 (2007) 査読有
  184. Miyoshi K, Narita M, Takatsu M and Suzuki T: mGlu5 receptor and protein kinase C implicated in the development and maintenance of neuropathic pain following chronic ethanol consumption. Eur. J. Pharmacol., 562, 208-211 (2007) 査読有
  185. Narita M, Nakajima M, Miyoshi K, Narita M, Nagumo Y, Miyatake M, Yajima Y, Yanagida K, Yamazaki M, Suzuki T: Role of spinal voltage-dependent calcium channel a2δ−1 subunit in the expression of a neuropathic pain-like state in mice. Life Sci., 80, 2015-2024 (2007) 査読有
  186. Shiokawa M, Narita M, Nakamura A, Kurokawa K, Inoue T and Suzuki T: Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis. Eur. J. Pharmacol., 570, 108-110 (2007) 査読有
  187. Mori T, Ito S, Kita T, Narita M, Suzuki T, Matsubayashi K and Sawaguchi T.: Oxidative stress in methamphetamine-induced self-injurious behavior in mice. Behav. Pharmacol., 18, 239-249 (2007) 査読有
  188. Suzuki T, Shindo K, Miyatake M, Kurokawa K, Higashiyama K, Suzuki M and Narita M: Lack of development of behavioral sensitization to methylphenidate in mice : Correlation with reversible astrocytic activation. Eur. J. Pharmacol., 574, 39-48 (2007) 査読有
  189. Nemoto T, Fujii H, Narita M, Miyoshi K, Nakamura A, Suzuki T and Nagase H: Synthesis of a novel 6,14-epoxymorphinan derivative and its pharmacology. Bioorg. Med. Chem. Lett., 18, 6398-6401 (2008) 査読有
  190. Narita M, Hashimoto K, Amano T, Narita M, Niikura K, Nakamura A and Suzuki T: Post-synaptic action of morphine on glutamatergic neuronal transmission related to the descending antinociceptive pathway in the rat thalamus. J. Neurochem., 104, 469-478 (2008) 査読有
  191. Niikura K, Kobayashi Y, Okutsu D, Furuya M, Kawano K, Maitani Y, Suzuki T and Narita M: Implication of spinal protein kinase Cgamma isoform in activation of the mouse brain by intrathecal injection of the protein kinase C activator phorbol 12,13-dibutyrate using functional magnetic resonance imaging analysis. Neurosci. Lett., 433, 6-10 (2008) 査読有
  192. Niikura K, Narita M, Okutsu D, Tsurukawa Y, Nanjo K, Kurahashi K, Kobayashi Y and Suzuki T: Implication of endogenous beta-endorphin in the inhibition of the morphine-induced rewarding effect by the direct activation of spinal protein kinase C in mice. Neurosci. Lett., 433, 54-58 (2008) 査読有
  193. Narita M, Shimamura M, Imai S, Kubota C, Yajima Y, Takagi T, Shiokawa M, Inoue T, Suzuki M and Suzuki T: Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice. Neuroscience, 152, 477-486 (2008) 査読有
  194. Niikura K, Narita M, Narita M, Nakamura A, Okutsu D, Ozeki A, Kurahashi K, Kobayashi Y, Suzuki M and Suzuki T: Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state. Neurosci. Lett., 435, 257-262 (2008) 査読有
  195. Narita M, Nakamura A, Ozaki M, Imai S, Miyoshi K, Suzuki M and Suzuki T: Comparative Pharmacological Profiles of Morphine and Oxycodone under a Neuropathic Pain-Like State in Mice: Evidence for Less Sensitivity to Morphine. Neuropsychopharmacol., 33, 1097-1112 (2008) 査読有
  196. Nemoto T, Fujii H, Narita M, Miyoshi K, Nakamura A, Suzuki T and Nagase H: Syntheses of 4,6′-epoxymorphinan derivatives and their pharmacologies. Bioorg. Med. Chem., 16, 4304-12 (2008) 査読有
  197. Matsuzawa-Yanagida K, Narita M, Nakajima M, Kuzumaki N, Niikura K, Nozaki H, Takagi T, Tamai E, Hareyama N, Terada M, Yamazaki M and Suzuki T: Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychophrmacol., 33, 1952-65 (2008) 査読有
  198. Terada M, Kuzumaki N, Hareyama N, Imai S, Niikura K, Narita M, Yamazaki M, Suzuki T and Narita M: Suppression of enriched environment-induced neurogenesis in a rodent model of neuropathic pain. Neurosci. Lett., 440, 314-318 (2008) 査読有
  199. Nakamura A, Narita M, Miyoshi K, Shindo K, Okutsu D, Suzuki M, Higashiyama K and Suzuki T: Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice. Psychopharmacol., 200, 307-316 (2008) 査読有
  200. Narita M, Takei D, Shiokawa M, Tsurukawa Y, Matsushima Y, Nakamura A, Takagi S, Asato M, Ikegami D, Narita M, Amano T, Niikura K, Hashimoto K, Kuzumaki N and Suzuki T: Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer. Eur. J. Pharmacol., 600, 105-109 (2008) 査読有
  201. Matsumoto K, Takayama H, Narita M, Nakamura A, Suzuki M, Suzuki T, Murayama T, Wongseripipatana S, Misawa K, Kitajiam M, Tashima K and Horie S: MGM-9[(E)-methyl2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro -1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine:A novel dual-acting μ− and κ−opioid agonist with potent antinociceptiveand weak rewarding effects in mice. Neuropharmacol., 55, 154-65 (2008) 査読有
  202. 塩川 満、成田 年、武井大輔、松島勇紀、高木茂実、橋本敬輔、池上大悟、朝戸めぐみ、平山重人、成田道子、新倉慶一、葛巻直子、鈴木 勉: モルヒネの副作用対策における新規抗精神病薬アリピプラゾールの有用性. 日本緩和医療薬学会雑誌 (2008) 査読有
  203. Hashimoto K, Amano T, Sakai N, Suzuki T and Narita M: Cell-dependentphysiological synaptic action of morphine in the rat habenular nucleus: morphineboth inhibits and facilitates excitatory synaptic transmission. Neurosci. Lett., 451, 270-273 (2009) 査読有
  204. Hashimoto K, Amano T, Kasakura A, Uhl GR, Sora I, Sakai N, Kuzumaki N, Suzuki T and Narita M: μ−Opioid receptor-independent fashion of the suppression of sodium currents by μ−opioid analgesics in thalamic neurons. Neurosci Lett., 453, 62-67 (2009) 査読有
  205. Fujii H, Watanabe A, Nemoto T, Narita M, Miyoshi K, Nakamura A, Suzuki T and  Nagase H: Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists. Bioorg Med Chem Lett., 19, 438-441 (2009) 査読有
  206. Furuta S, Shimizu T, Narita M. Matsumoto K, Kuzumaki N, Horie S, Suzuki T and Narita M: Subdiaphragmatic vagotomy promotes nociceptive sensitivity of deep tissue in rats. Neuroscience, 164, 1252-1262 (2009) 査読有
  207. Minami K, Hasegawa M, Ito H, Nakamura A, Tomii T, Matsumoto M, Orita S, Matsushima S, Miyoshi T, Masuno K, Torii M, Koike K, Shimada S, Kanemasa T, Kihara T, Narita M, Suzuki T and Kato A: Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models. J. Pharmacol. Sci., 111, 60-72 (2009) 査読有
  208. Taketa Y, Niikura K, Kobayashi Y, Furuya M, Shimizu T, Narita M, Imai S, Kuzumaki N, Maitani Y, Yamazaki M, Inada E, Iseki M, Suzuki T and Narita M: Direct evidence for the ongoing brain activation by enhanced dynorphinergic system in the spinal cord under inflammatory noxious stimuli. Anesthesiolosy, 112, 418-431 (2010) 査読有
  209. Kuzumaki N, Ikegami D, Tamura R, Sasaki T, Niikura K, Narita M, Miyashita K, Imai S, Takeshima H, Ando T, Igarashi K, Kanno J, Ushijima T, Suzuki T. and Narita M: Hippocampal epigenetic modification at the doublecortin gene is involved in the impairment of neurogenesis with aging. Synapse, 64, 611-616 (2010) 査読有
  210. Kumakura K, Nomura H, Toyoda T, Hashikawa K, Noguchi T, Takeda K, Ichijo H, Tsunoda M, Funatsu T, Ikegami D, Narita M and Suzuki T: Hyperactivity in novel environment with increased dopamine and impaired novelty preference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice. Neurosci Res., 66, 313-320 (2010) 査読有
  211. Ikegami D, Narita M, Imai S, Miyashita K, Tamura R, Narita M, Takagi S, Yokomizo A, Takeshima H, Ando T, Igarashi K, Kanno J, Kuzumaki N, Ushijima T and Suzuki T: Epigenetic modulation at the CCR2 gene correlates with the maintenance of behavioral sensitization to methamphetamine. Addict. Biol., 15, 358-361 (2010) 査読有
  212. Kuzumaki N, Ikegami D, Imai S, Narita M, Tamura R, Yajima M, Suzuki A, Miyashita K, Takeshima K, Ando T, Ushijima T, Suzuki T and Narita M: Enhanced IL-1β production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice. Synapse, 64, 721-728 (2010) 査読有
  213. Narita M, Matsushima Y, Nikura K, Narita M, Takagi S, Nakahara, K, Kurahashi K, Abe M, Saeki M, Asato M, Imai S, Ikeda K, Kuzumaki N and Suzuki T: Implication of dopaminergic projection from the ventral tegmental area to the    anterior cingulate cortex in μ−opioid-induced place preference. Addict. Biol., 15, 434-447 (2010) 査読有
  214. Kuzumaki N, Ikegami D, Tamura R, Hareyama N, Imai S, Narita M, Torigoe K, Niikura K, Takeshima H, Ando T, Igarashi K, Kanno J, Ushijima T, Suzuki T and Narita M: Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene is involved in enriched environment-induced neurogenesis. Hippocampus, 21,127-132 (2011) 査読有
  215. Niikura K, Furuya M, Narita M, Torigoe K, Kobayashi Y, Takemura Y, Yamazaki M, Horiuchi H, Enomoto T, Iseki M, Kinoshita H, Tomiyasu S, Imai S, Kuzumaki N, Suzuki T and Narita M: Enhancement of glutamatergic transmission in the cingulate cortex in response to mild noxious stimuli under a neuropathic pain-like state. Synapse, 65,424-432 (2011) 査読有
  216. Rahmadi M, Narita M, Yamashita A, Imai S, Kuzumaki N and Suzuki T: Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran. Synapse, 65,652-7 (2011)査読有
  217. Yoshizawa K, Narita M, Mori T, Miyatake M, Isotani K, Tomiyasu S, Tsukiyama Y and Suzuki T: Role of dopamine D2 and D3 receptors in mediating the U-50,488H discriminative cue: Comparison with methamphetamine and cocaine. Addict Biol., 17,949-955 (2012) 査読有
  218. Yoshizawa K, Narita M, Saeki M, Narita M, Isotani K, Horiuchi H, Imai S, Kuzumaki N and Suzuki T: Activation of extracellular signal-regulated kinase is critical for the discriminative stimulus effects induced by U-50,488H. Addict Biol., 65: 1052-61. (2011) 査読有
  219. Imai S, Saeki M, Yanase M, Horiuchi H, Abe M, Narita M, Kuzumaki N, Suzuki T, and Narita M: Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J Neurosci, 31,15294-15299 (2011) 査読有
  220. Furuta S, Matsumoto K, Horie S, Suzuki T, and Narita M: Subdiaphragmatic vagotomy induces sensitization of primary afferent fibers and its beneficial treatment of a 5-HT4 receptor agonist mosapride. Japanese journal of pharmaceutical palliative care and sciences査読有
  221. Tsukahara-Ohsumi Y, Tsuji F, Niwa M, Hata T, Narita M, Suzuki T, Sasano M, Aono H.The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain. Eur J Pharmacol. 671,53-60. 査読有
  222. Nakamura A, Hasegawa M, Ito H, Minami K, Koike K, Habu-Tomita N, Nanba K, Hamaguchi K, Noshi E, Hashimoto H, Nishino I, Okabayashi Y, Koyabu K, Kihara T, Iwamoto Y, Inoue Y, Narita M, Suzuki T, Kato A.Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl. J Pain Palliat Care Pharmacother. 2011; 25(4): 318-34. 査読有
  223. Takemura Y, Furuta S, Hirayama S, Miyashita K, Imai S, Narita M, Kuzumaki N, Tsukiyama Y, Yamazaki M, Suzuki T and Narita M: Upregulation of bradykinin receptors is implicated in the pain associated with caerulein-induced acute pancreatitis. Synapse, 65, 608-16 (2011) 査読有
  224. Takemura Y, Yamashita A, Horiuchi H, Furuya M, Yanase M, Niikura K, Imai S, Hatakeyama N, Kinoshita H, Tsukiyama Y, Senba E, Matoba M, Kuzumaki N, Yamazaki M, Suzuki T and Narita M: Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis. Synapse, 65,668-76 (2011) 査読有
  225. Narita M, Niikura K, Nanjo-Niikura K, Narita M, Furuya M, Yamashita A, Saeki M, Matsushima Y, Imai S, Shimizu T, Asato M, Kuzumaki N, Okutsu D, Miyoshi K, Suzuki M, Tsukiyama Y, Konno M, Yomiya K, Matoba M and Suzuki T: Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain, 152,1358-72 (2011) 査読有
  226. Yamamizu K, Furuta S, Katayama S, Narita M, Kuzumaki N, Imai S, Nagase H, Suzuki T, Narita M and Yamashita JK: The kappa-opioid system regulates endothelial cell differentiation and pathfinding in vascular development. Blood, 118, 775-85 (2011)査読有
  227. Imai S, Sudo Y, Nakamura A, Ozeki A, Asato M, Hojo M, Devi LA, Kuzumaki N, Suzuki T, Uezono Y, Narita M. Possible involvement of β-endorphin in a loss of the coordinated balance of μ-opioid receptors trafficking processes by fentanyl. Synapse. 65, 962-6 (2011). 査読有
  228. Mori T, Yoshizawa K, Nomura M, Isotani K, Torigoe K, Tsukiyama Y, Narita M and Suzuki T: Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50,488H. Addict Biol.,17, 717-24 (2012) 査読有
  229. Furuta S, Watanabe L, Doi S, Horiuchi H, Matsumoto K, Kuzumaki N, Suzuki T, Narita M. Subdiaphragmatic vagotomy increases the sensitivity of lumbar Aδ primary afferent neurons along with voltage-dependent potassium channels in rats. Synapse. 66, 95-105. (2012)査読有
  230. Furuta S, Matsumoto K, Horie S, Suzuki T, Narita M. Subdiaphragmatic vagotomy induces a functional change in visceral Aδ primary afferent fibers in rats. Synapse. 66, 369-71. (2012) 査読有
  231. Torigoe K, Mori T, Shibasaki M, Yoshizawa K, Narita M, Suzuki T. Olanzapine suppresses the rewarding and discriminative stimulus effects induced by morphine. Synapse. 66, 174-9. (2012) 査読有
  232. Torigoe K, Nakahara K, Rahmadi M, Yoshizawa K, Horiuchi H, Hirayama S, Imai S, Kuzumaki N, Itoh T, Yamashita A, Shakunaga K, Yamasaki M, Nagase H, Matoba M, Suzuki T, Narita M. Usefulness of olanzapine as an adjunct to opioid treatment and for the treatment of neuropathic pain. Anesthesiology. 116, 159-69. (2012)査読有
  233. Enomoto T, Yamashita A, Torigoe K, Horiuchi H, Hirayama S, Nakahara K, Yanase M, Sakai H, Ikegami D, Nagase H, Suzuki T, Iseki M, Inada E, Narita M. Effects of mirtazapine on sleep disturbance under neuropathic pain-like state. Synapse. 66, 483-8. (2012) 査読有
  234. Kuzumaki N, Suzuki A, Narita M, Hosoya T, Nagasawa A, Imai S, Yamamizu K, Morita H, Nagase H, Okada Y, Okano HJ, Yamashita JK, Okano H, Suzuki T, Narita M. Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells. Br J Cancer.106. 1148-52. (2012)査読有
  235. Suzuki M, Narita M, Ashikawa M, Furuta S, Matoba M, Sasaki H, Yanagihara K, Terawaki K, Suzuki T, Uezono Y. Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia. Synapse. 66, 747-51. (2012)査読有
  236. Suzuki M, Narita M, Hasegawa M, Furuta S, Kawamata T, Ashikawa M, Miyano K, Yanagihara K, Chiwaki F, Ochiya T, Suzuki T, Matoba M, Sasaki H, Uezono Y. Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance P and μ-opioid receptors in the spinal cord of mice. Anesthesiology. 117, 847-56. (2012)査読有
  237. Kuzumaki N, Suzuki A, Narita M, Hosoya T, Nagasawa A, Imai S, Yamamizu K, Morita H, Suzuki T, Okada Y, Okano HJ, Yamashita JK, Okano H, Narita M. Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer. PLoS One.;7:e44368 (2012)査読有
  238. Takada T, Yamashita A, Date A, Yanase M, Suhara Y, Hamada A, Sakai H, Ikegami D, Iseki M, Inada E, Narita M. Changes in the circadian rhythm of mRNA expression for µ-opioid receptors in the periaqueductal gray under a neuropathic pain-like state. Synapse. 67, 216-23 (2013)査読有
  239. Imai S, Ikegami D, Yamashita A, Shimizu T, Narita M, Niikura K, Furuya M, Kobayashi Y, Miyashita K, Okutsu D, Kato A, Nakamura A, Araki A, Omi K, Nakamura M, James Okano H, Okano H, Ando T, Takeshima H, Ushijima T, Kuzumaki N, Suzuki T, Narita M. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain. Brain.136, 828-43 (2013)査読有
  240. Yoshizawa K, Mori T, Ueno T, Nishiwaki M, Shibasaki M, Shimizu N, Narita M, Suzuki T. Involvement of serotonin receptor mechanisms in the discriminative stimulus effects of ketamine in rats. J Pharmacol Sci. 121, 237-41. (2013)査読有
  241. Sakai H, Sagara A, Matsumoto K, Hasegawa S, Sato K, Nishizaki M, Shoji T, Horie S, Nakagawa T, Tokuyama S, Narita M. 5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines. PLoS One. 8:e54788 (2013)査読有
  242. Shibasaki M, Watanabe K, Takeda K, Itoh T, Tsuyuki T, Narita M, Mori T, Suzuki T.  Effect of chronic ethanol treatment on μ-opioid receptor function, interacting proteins and morphine-induced place preference. Psychopharmacology 228, 207-15 (2013)査読有
  243. Matsumoto K, Nakajima T, Sakai H, Kato S, Sagara A, Arakawa K, Tashima K, Narita M, Horie S. Increased Expression of 5-HT3 and NK 1 Receptors in 5-Fluorouracil-Induced Mucositis in Mouse Jejunum. Dig Dis Sci. 58, 3440-51 (2013) 査読有
  244. Mori T, Yoshizawa K, Ueno T, Nishiwaki M, Shimizu N, Shibasaki M, Narita M, Suzuki T. Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats. Behav Pharmacol. 24, 275-81 (2013)査読有
  245. Sakai H, Watanabe Y, Honda M, Tsuiki R, Ueda Y, Nagai Y, Narita M, Misawa M, Chiba Y: Involvement of the Tyr kinase/JNK pathway in carbachol-induced bronchial smooth muscle contraction in the rat. Anesthesiology.118, 1076-85 (2013)
  246. Nakamura A, Hasegawa M, Minami K, Kanbara T, Tomii T, Nishiyori A, Narita M, Suzuki T, Kato A. Differential activation of the u-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model. Br J Pharmacol.168, 375-88 (2013)
  247. Sakai H, Hara T, Todoroki K, Igarashi Y, Misawa M, Narita M, Chiba Y. Elevated guanylate cyclase and cyclic-guanosine monophosphate-dependent protein kinase levels in nasal mucosae of antigen-challenged rats. Microvasc Res. 90, 150-3 (2013) (IF=2.93)
  248. Narita M, Imai S, Nakamura A, Ozeki A, Asato M, Rahmadi M, Sudo Y, Hojo M, Uezono Y, Devi LA, Kuzumaki N, Suzuki T: Possible involvement of prolonging spinal μ-opioid receptor desensitization in the development of antihyperalgesic tolerance to μ-opioids under a neuropathic pain-like state. Addict Biol, 18, 614-22 (2013)
  249. Yamamizu K, Furuta S, Hamada Y, Yamashita A, Kuzumaki N, Narita M, Doi K, Katayama S, Nagase H, Yamashita JK, Narita M: k Opioids inhibit tumor angiogenesis by suppressing VEGF signaling. Sci Rep, 3, 3213 (2013)
  250. Ito H, Yanase M, Yamashita A, Kitabatake C, Hamada A, Suhara Y, Narita M, Ikegami D, Sakai H, Yamazaki M, Narita M: Analysis of sleep disorders under pain using an optogenetic tool: possible involvement of the activation of dorsal raphe nucleus-serotonergic neurons. Mol Brain, 6, 59 (2013)
  251. Odo M, Koh K, Takada T, Yamashita A, Narita M, Kuzumaki N, Ikegami D, Sakai H, Iseki M, Inada E, Narita M: Changes in circadian rhythm for mRNA expression of melatonin 1A and 1B receptors in the hypothalamus under a neuropathic pain-like state. Synapse, 68, 253-8 (2014)
  252. Yamashita A, Hamada A, Suhara Y, Kawabe R, Yanase M, Kuzumaki N, Narita M, Matsui R, Okano H, Narita M: Astrocytic activation in the anterior cingulate cortex is critical for sleep disorder under neuropathic pain. Synapse, 68, 235-47 (2014)
  253. Zhao M, Nakamura S, Miyake T, So K, Shirakawa H, Tokuyama S, Narita M, Nakagawa T, Kaneko S. Pharmacological characterization of standard analgesics on oxaliplatin-induced acute cold hypersensitivity in mice. J Pharmacol Sci., 124, 514-7 (2014)
  254. Sakai H, Sato K, Takase K, Hirosaki A, Jo A, Sugiyama R, Chiba Y, Narita M*. The gene expression of aquaporins in various cutaneous tissues of the mouse. J Exp Integr Med. 4, 75-79. (2014)
  255. Sakai H, Watanabe A, Fujita A, Misawa M, Narita M, Chiba Y. Augmented bronchial smooth muscle contractility induced by aqueous cigarette smoke extract in rats. J Smooth Muscle Res.50, 39-47 (2014)
  256. Sakai H, Sagara A, Arakawa K, Sugiyama R, Hirosaki A, Takase K, Jo A, Sato K, Chiba Y, Yamazaki M, Matoba M, Narita M*. Mechanisms of cisplatin-induced muscle atrophy. Toxicol Appl Pharmacol. 278, 190-9 (2014)
  257. Sakai H, Sagara A, Matsumoto K, Jo A, Hirosaki A, Takase K, Sugiyama R, Sato K, Ikegami D, Horie S, Matoba M, Narita M*. Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon. Pharmacol Res., 87, 71-9 (2014)
  258. Matsumoto K, Narita M, Muramatsu N, Nakayama T, Misawa K, Kitajima M, Tashima K, Devi LA, Suzuki T, Takayama H, Horie S.: Orally active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice. J Pharmacol Exp Ther., Mar;348, 383-92 (2014)
  259. Sakai H, Sato K, Kai Y, Shoji T, Hasegawa S, Nishizaki M, Sagara A, Yamashita A, Narita M; Distribution of aquaporin genes and selection of individual reference genes for quantitative real-time RT-PCR analysis in multiple tissues of the mouse. Can J Physiol Pharmacol. 92, 789-96 (2014)
  260. Kobori T, Fujiwara S, Miyagi K, Harada S, Nakamoto K, Nakagawa T, Takahashi H, Narita M, Tokuyama: Involvement of Moesin in the Development of Morphine Analgesic Tolerance through P-glycoprotein at the Blood-Brain Barrier. Drug Metab Pharmacokinet, 29, 482-9 (2014)
  261. Koh K, Hamada A, Hamada Y, Yanase M, Sakaki M, Someya K, Narita M, Kuzumaki N, Ikegami D, Sakai H, Iseki M, Inada E, Narita M: Possible involvement of activated locus coeruleus-noradrenergic neurons in pain-related sleep disorders. Neurosci lett, 589, 200-6 (2015)
  262. Saisu H, Igarashi K, Narita M, Ikegami D, KuzumakiN, WajimaK, Nakagawa T, Narita M. Neuropathic pain-like stimuli change the expression of ribosomal proteins in the amygdala: genome-wide search for a “pain-associated anxiety-related factor”. J. Pharm. Palliat. Care Sci, 8, 47-57 (2015)
  263. Suzuki M, Chiwaki F, Sawada Y, Ashikawa M, Aoyagi K, Fujita T, Yanagihara K, Komatsu M, Narita M, Suzuki T, Nagase H, Kushima R, Sakamoto H, Fukagawa T, Katai H, Nakagama H, Yoshida T, Uezono Y, Sasaki H: Peripheral opioid antabonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo. PLoS One, 10, e0123407 (2015)
  264. Juliandi B, Tanemura K, Igarashi K, Tominaga T, Furukawa Y, Otsuka M, Moriyama N, Ikegami D, Abematsu M, Sanosaka T, Tsujimura K, Narita M, Kanno J, Nakashima K: Reduced Adult Hippocampal Neurogenesis and Cognitive Impairments following Prenatal Treatment of the Antiepileptic Drug Valproic Acid. Stem Cell Reports, 5, 1-14 (2015)
  265. Sakai H, Sato K, Kai Y, Chiba Y, Narita M: Denatonium and 6-n-propyl-2-thiouracil, agonists of bitter taste receptor, inhibit contraction of various types of smooth muscles in the rat and mouse. Biol Pharm Bull, 39, 33-41 (2016)
  266. Hori N, Narita M, Yamashita A, Horiuchi H, Hamada Y, Kondo T, Watanabe M, Igarashi K, Kawata M, Shibasaki M, Yamazaki M, Kuzumaki N, Inada E, Ochiya T, Iseki M, Mori T, Narita M: Changes in the expression of IL-6-mediated microRNAs in the dorsal root ganglion under neuropathic pain in mice. Synapse, 70, 317-24 (2016)
  267. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, Koya I, Okada Y, Kimura T, Tsuchiya Y, Suzuki S, Ohishi N, kuzumaki N, Matsuzaki Y, Narita M, Ikeda E, Okanoya K, Seino K, Saya H, Okano H, Miura K: Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun, 7, 11471 (2016)
  268. Ochiai W, Kaneta M, Nagae M, Yuzuhara A, Li X, Suzuki H, Hanagata M, Kitaoka S, Kusunoki Y, Kon R, Miyashita K, Masukawa D, Ikarashi N, Narita M, Suzuki T, Sugiyama K: Mice with neuropathic pain exhibit morphine tolerance due to a decrease in the morphine concentration in the brain. Eur J Pharm Sci, 92, 298-304 (2016)
  269. Doi S, Mori T, Uzawa N, Arima T, Takahashi T, Uchida M, Yawata A, Narita M, Uezono Y, Suzuki T, Narita M: Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist. Mol Pain, 12, 1744806916654146 (2016)
  270. Sakai H, Kai Y, Takase K, Sato K, Kimura M, Tabata S, Yaegashi M, Sato F, Yomoto T, Narita M: Role of peptide YY in 5-fluorouracil-induced reduction of dietary intake. Clin Exp Pharmacol Physiol, 43, 753-759 (2016)
  271. Sakai H, Kai Y, Oguchi A, Kimura M, Tabata S, Yaegashi M, Saito T, Sato K, Sato F, Yumoto T, Narita M: Curcumin Inhibits 5-Fluorouracil-induced Up-regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development. Basic Clin Pharmacol Toxicol, 110, 540-547 (2016)
  272. Sagara A, Igarashi K, Otsuka M, Karasawa T, Gotoh N, Narita M, Kuzumaki N, Narita M, Kato Y.: Intrinsic resistance to 5-fluorouracil in a brain metastatic variant of human breast cancer cell line, MDA-MB-231BR. Plos One 11, e0164250 (2016)
  273. Wakaizumi K, Kondo T, Hamada Y, Narita M, Kawabe R, Narita H, Watanabe M, Kato S, Senba E, Kobayashi K, Kuzumaki N, Yamanaka A, Morisaki H, Narita M.: Involvement of mesolimbic dopaminergic network in neuropathic pain relief by treadmill exercise: A study for specific neural control with Gi-DREADD in mice. Mol Pain, 12, 1744806916681567 (2016)
  274. Sagara A,Karasawa T, Igarashi K, Otsuka M, Sugiura R, Kodama A, Yamashita M, Narita M, Kato Y.: Controlled Secretion of the Anticancer Protein MDA-7 from Engineered Mesenchymal Stem Cells. Biol Pharm Bull, 40, 113-117 (2017)
  275. Sagara A, Igarashi K, Otsuka M, Kodama A, Yamashita M, Sugiura R, Karasawa T, Arakawa K, Narita M, Kuzumaki N, Narita M, Kato Y: Endocan as a prognostic biomarker of triple-negative breast cancer. Breast Cancer Res Treat, 161, 269-278 (2017)
  276. Hamada Y, Tasaki Y, Morita K, Yamamizu K, Narita M, Matsuyama F, Suzuki M, Ikegami D, Arakawa K, Nagumo Y, Kawata M, Uezono Y, Nagase H, Aoki K, Yamashita JK, Kuzumaki N, Narita M.: The κ-opioid receptor agonist nalfurafine enhances the chemotherapy-induced survival advantage in pancreatic cancer-bearing mice. Jpn J Pharm Palliat Care Sci, 10, 7-12 (2017)
  277. Narita M, Shimura E, Nagasawa A, Aiuchi T, Suda Y, Hamada Y, Ikegami D, Iwasawa C, Arakawa K, Igarashi K, Kuzumaki N, Yoshioka Y, Ochiya T, Takeshima H, Ushijima T, Narita M.: Epigenetic mechanisms of the gefitinib-induced epithelial-to-mesenchymal transition in non-small-cell lung cancer cells. PLoS One, e0172115 (2017
  278. Morikawa S, Ikegaya Y, Narita M, Tamura H: Activation of perineuronal netexpressing excitatory neurons during associative memory encoding and retrieval. Sci Rep, 7, 46024 (2017).
  279. Sakai H, Sato K, Sato F, Kai Y, Mandokoro K, Matsumoto K, Kato S, Yumoto T, Narita M, Chiba Y: Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling. Inflamm Res, 66, 663-678 (2017)
  280. Sakai H, Kimura M, Isa Y, Yabe S, Maruyama A, Tsuruno Y, Kai Y, Sato F, Yumoto T, Chiba Y, Narita M: Effect of acute treadmill exercise on cisplatin-induced muscle atrophy in the mouse. Pflugers Arch, in presss
  281. Sakai H, Yabe S, Sato K, Kai Y, Sato F, Yumoto T, Inoue Y, Narita M, Matsumoto K, Kato S, Chiba Y: ELR+ chemokine-mediated neutrophil recruitment is involved in 2,4,6-trinitrochlorobenzene-induced contact hypersensitivity. Clin Exp Pharmacol Physiol, in press

 

Back

 

Back to Top